SPH4336 Tablets Placebo
Sponsors
Shanghai Pharmaceuticals Holding Co., Ltd
Conditions
Locally Advanced or Metastatic Breast Cancer
Phase 2
Phase II/III Study of SPH4336 Combined With Letrozole vs Placebo Combined With Letrozole in First-line Treatment of Breast Cancer
RecruitingNCT05744687
Start: 2023-04-24End: 2026-05-31Target: 374Updated: 2025-08-17
Safety and Efficacy of SPH4336 in Combination With Endocrine Therapy in the Treatment of Locally Advanced or Metastatic Breast Cancer
RecruitingNCT05860465
Start: 2023-09-08End: 2026-12-30Target: 254Updated: 2026-01-14